FACULTY
Joshua J. Neumiller, PharmD, CDCES, FASCP, FADCES
Professor
Department of Pharmacotherapy
College of Pharmacy and Pharmaceutical Sciences
Washington State University
Spokane, WA
Jay H. Shubrook DO, FAAFP, FACOFP
Professor
Department of Clinical Sciences and Community Health
Touro University California
Vallejo, CA
PROGRAM OVERVIEW
This enduring activity is designed to help clinicians simultaneously address weight management and glycemic control in patients with type 2 diabetes (T2DM). Along with didactic instruction, the activity will include small group case-study discussions to provide practice in identifying and treating patients who would benefit from a weight-centric approach to type 2 diabetes management, ultimately improving outcomes of patients affected by this complex, chronic disease.
TARGET AUDIENCE
This educational activity is intended for US primary care physicians, physician assistants, and nurse practitioners who treat patients with T2DM and obesity.
LEARNING OBJECTIVES
- Intensify or change therapy according to guidelines when patients with T2DM fail to meet their weight management and/or glycemic goals
- Integrate weight loss into treatment strategies for patients with type 2 diabetes and obesity/overweight using up-to-date guidelines
- Apply clinical data on incretin-based therapies that facilitate both weight management and glycemic control
- Utilize shared decision-making when selecting treatments for patients with type 2 diabetes based on patients’ values, preferences and personal contexts
JOINT ACCREDITATION STATEMENT
In support of improving patient care, Med Learning Group is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
PHYSICIAN CREDIT DESIGNATION STATEMENT
Med Learning Group designates this enduring activity for a maximum of 1.5 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the enduring activity.
NURSES (ANCC) CREDIT DESIGNATION
Med Learning Group designates this activity for a maximum of 1.5 ANCC contact hours.
DISCLOSURE POLICY STATEMENT
In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Integrity and Independence in Accredited Continuing Education, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
DISCLOSURE OF FINANCIAL RELATIONSHIPS
| Joshua J. Neumiller, PharmD, CDCES | Consulting Fees | Sanofi, Bayer, Boehringer Ingelheim, and Eli Lilly |
| Grants | Dompe and Novo Nordisk | |
| Speakers Bureau | Dexcom | |
| Jay H. Shubrook, DO, FAAFP, FACOFP | Consulting Fees | Eli Lilly, Madrigal, Nevro, NovoNordisk. In additional fees for non-CME/CE services received from Sanofi |
| Advisory Board | Astra Zeneca, Eli Lilly, Nevro |
All relevant financial relationships have been mitigated.
Content Review
The content of this activity was independently peer reviewed by a physician and nurse reviewer.
Individuals in Control of the Content of the Activity
The individuals in control of the content of this activity reported the following financial relationships or relationships to products or devices they have with ineligible companies related to the content of this CE activity:
- Matthew Frese, General Manager of Med Learning Group has nothing to disclose.
- Christina Gallo, SVP, Educational Development for Med Learning Group has nothing to disclose.
- Sarah Milano, RN, MSN, has nothing to disclose.
- A medical reviewer from CME Peer Review LLC, has nothing to disclose.
- Lauren Welch, MA, VP, Outcomes and Accreditation for Med Learning Group has nothing to disclose.
- Cindy Lampner, MSLIS, Medical Director for Med Learning Group, has nothing to disclose.
- Melissa A. Johnson, Program Director for Med Learning Group has nothing to disclose.
- Millena De Brito, Program Coordinator for Med Learning Group has nothing to disclose.
- Russie Allen, Accreditation and Outcomes Manager for Med Learning Group has nothing to disclose.
DISCLOSURE OF UNLABELED USE
Med Learning Group requires that faculty participating in any CE activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States. During the course of this lecture, the faculty may mention the use of medications for both FDA-approved and non-approved indications.
METHOD OF PARTICIPATION
There are no fees for participating and receiving CE credit for this activity.
In order to obtain your certificate for the mentioned accreditation, participants need to successfully complete the associated pre/post activities and evaluation.
Your certificate will be provided as a downloadable file.
DISCLAIMER
Med Learning Group makes every effort to develop CE activities that are scientifically based. This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making expertise before applying any information, whether provided here or by others, for any professional use.
For CME questions, please contact Med Learning Group at [email protected]
Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at www.medlearninggroup.com/privacy-policy/
AMERICANS WITH DISABILITIES ACT
Event staff will be glad to assist you with any special needs. Please contact Med Learning Group at [email protected]
RELEASED DATE: June 06, 2024
EXPIRATION DATE: June 06, 2025
Copyright ©2024 Med Learning Group. All rights reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Med Learning Group is prohibited.
